PT  - JOURNAL ARTICLE
AU  - Vinall, Maria
ED  - Burmester, Gerd-Rüdiger
TI  - Short- and Long-Term Efficacy of Tofacitinib in the Treatment of Patients with RA and an Inadequate Response to TNF Inhibitors
DP  - 2012  01
TA  - MD Conference Express
PG  - 18--18
VI  - 12
IP  - 19
4099  - http://mdc.sagepub.com/content/12/19/18.1.short
4100  - http://mdc.sagepub.com/content/12/19/18.1.full
AB  - Treatment with the oral Janus kinase (JAK) inhibitor tofacitinib was associated with an improvement in the signs and symptoms of rheumatoid arthritis (RA), physical function, and patient reported outcomes in RA patients with an inadequate response to tumor necrosis factor inhibitors (TNFi). The improved response was maintained over 24 months.